Options: Hide MedDRA Preferred Terms
MedDRA Preferred Term | Side effect | Data for drug | Placebo | Labels | ||
---|---|---|---|---|---|---|
1 | 2 | 3 | ||||
Dysgeusia | Dysgeusia | 4% | 1% | x | x | x |
Eructation | Eructation | 4% | 1% | x | x | x |
Dyspepsia | Dyspepsia | 3% | 2% | x | x | x |
Anaphylactic shock | Anaphylactic shock | postmarketing | x | x | x | |
Haemorrhagic disorder | Haemorrhagic disorder | postmarketing | x | x | x | |
Constipation | Constipation | x | x | x | ||
Dermatitis | Rash | x | x | x | ||
Rash | Rash | x | x | x | ||
Gastrointestinal disorder | Gastrointestinal disorder | x | x | x | ||
Pruritus | Pruritus | x | x | x | ||
Vomiting | Vomiting | x | x | x | ||
Aspartate aminotransferase increased | Aspartate aminotransferase increased | x | x | x | ||
Alanine aminotransferase increased | Alanine aminotransferase increased | x | x | x | ||
Malnutrition | Malnutrition | x | x | x |
Information about indications was extracted from the indications and usage sections of the labels.
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |